Inactivation of the Carney complex gene 1 (PRKAR1A) alters spatiotemporal regulation of cAMP and cAMP-dependent protein kinase: a study using genetically encoded FRET-based reporters
Open Access
- 10 October 2013
- journal article
- research article
- Published by Oxford University Press (OUP) in Human Molecular Genetics
- Vol. 23 (5) , 1163-1174
Abstract
Carney complex (CNC) is a hereditary disease associating cardiac myxoma, spotty skin pigmentation and endocrine overactivity. CNC is caused by inactivating mutations in the PRKAR1A gene encoding PKA type I alpha regulatory subunit (RIα). Although PKA activity is enhanced in CNC, the mechanisms linking PKA dysregulation to endocrine tumorigenesis are poorly understood. In this study, we used Förster resonance energy transfer (FRET)-based sensors for cAMP and PKA activity to define the role of RIα in the spatiotemporal organization of the cAMP/PKA pathway. RIα knockdown in HEK293 cells increased basal as well as forskolin or prostaglandin E1 (PGE1)-stimulated total cellular PKA activity as reported by western blots of endogenous PKA targets and the FRET-based global PKA activity reporter, AKAR3. Using variants of AKAR3 targeted to subcellular compartments, we identified similar increases in the response to PGE1 in the cytoplasm and at the outer mitochondrial membrane. In contrast, at the plasma membrane, the response to PGE1 was decreased along with an increase in basal FRET ratio. These results were confirmed by western blot analysis of basal and PGE1-induced phosphorylation of membrane-associated vasodilator-stimulated phosphoprotein. Similar differences were observed between the cytoplasm and the plasma membrane in human adrenal cells carrying a RIα inactivating mutation. RIα inactivation also increased cAMP in the cytoplasm, at the outer mitochondrial membrane and at the plasma membrane, as reported by targeted versions of the cAMP indicator Epac1-camps. These results show that RIα inactivation leads to multiple, compartment-specific alterations of the cAMP/PKA pathway revealing new aspects of signaling dysregulation in tumorigenesis.Keywords
This publication has 69 references indexed in Scilit:
- An entirely specific type I A-kinase anchoring protein that can sequester two molecules of protein kinase A at mitochondriaProceedings of the National Academy of Sciences, 2011
- Optic atrophy 1 is an A‐kinase anchoring protein on lipid droplets that mediates adrenergic control of lipolysisThe EMBO Journal, 2011
- A Myristoyl/Phosphoserine Switch Controls cAMP-Dependent Protein Kinase Association to MembranesJournal of Molecular Biology, 2011
- PDE4D and PDE4B Function in Distinct Subcellular Compartments in Mouse Embryonic FibroblastsJournal of Biological Chemistry, 2011
- Alternate protein kinase A activity identifies a unique population of stromal cells in adult boneProceedings of the National Academy of Sciences, 2010
- Mutations and polymorphisms in the gene encoding regulatory subunit type 1-alpha of protein kinase A (PRKAR1A): an updateHuman Mutation, 2010
- A Molecular Switch for Targeting between Endoplasmic Reticulum (ER) and MitochondriaJournal of Biological Chemistry, 2008
- PGE1 stimulation of HEK293 cells generates multiple contiguous domains with different [cAMP]: role of compartmentalized phosphodiesterasesJournal of Cell Biology, 2006
- Systems analysis of PKA-mediated phosphorylation gradients in live cardiac myocytesProceedings of the National Academy of Sciences, 2006
- An anchored PKA and PDE4 complex regulates subplasmalemmal cAMP dynamicsThe EMBO Journal, 2006